DLK Investment Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$36K Hold
17,390
0.01% 82
2025
Q1
$38.3K Hold
17,390
0.02% 76
2024
Q4
$26.6K Sell
17,390
-500
-3% -$765 0.01% 84
2024
Q3
$35.6K Hold
17,890
0.01% 102
2024
Q2
$62.6K Hold
17,890
0.03% 90
2024
Q1
$49.6K Hold
17,890
0.02% 92
2023
Q4
$30.4K Buy
+17,890
New +$30.4K 0.01% 96